Introduction
Limb girdle muscular dystrophy (LGMD) describes a range of progressive muscle wasting diseases, which begin with the arms and pelvic girdle and are subclassified based on the underlying genetic defect. Miyoshi myopathy 1 is an autosomal recessive muscle wasting disease that begins in the distal, posterior leg muscles. The dysferlin gene was identified by reverse genetics as the locus of mutations that lead to both autosomal recessive LGMD type 2B 2 and Myoshi myopathy 3 . Dysferlin was so named as it showed homology to the C. elegans gene fer1. Mutations in fer1 cause defects in spermatoza motility due to a failure of the immature spermatid to fuse with membranous organelles 4 .
The ferlin family of proteins is characterised by a number of C2 domains, normally labelled A, B etc. starting from the N-terminus, and a C-terminal membrane spanning helix. C2 domains were originally characterised as the second homologous region amongst isoforms of Ca 2+ -dependent protein kinase C and were subsequently identified in a wide range of proteins (for a review see 5 ). C2 domains consist of around 130 residues, which form two four-stranded anti-parallel sheets, with two different topologies known 6; 7 . C2 domains classically bind phospholipids in a Ca 2+ -dependent manner, although some domains have been reported to bind to phospholipids independent of calcium ions and others have not had any binding properties demonstrated for them 8 . C2 domains also form protein-protein interactions and have been shown to have more than one interaction interface 9 .
In humans the ferlin family consists of three characterised proteins; dysferlin, myoferlin 10 and otoferlin 11 . Myoferlin has 56% sequence identity to dysferlin and is highly expressed in early differentiating myoblasts, in contrast to dysferlin, which is most highly expressed in mature myotubes 12; 13 Gene CG6468 was examined as it has multiple repeats of a -propeller like domain.
Much of the remainder of the protein was then found to be homologous to a region of It is therefore of interest to ascertain whether the DysF domain of the ferlins is a structured domain, particularly as a number of disease causing mutations map to this region 20 . We present here the solution structure of the inner DysF domain of myoferlin, the first structure of a DysF domain, which has a novel fold.
Results

Structure of the DysF domain
The solution structure of human myoferlin residues 923-1040, with an additional 5 amino acids (IDPFT) arising from the vector on the N-terminus, has been solved. The 20 lowest energy conformers compatible with 2810 distance restraints, 87 one bond N-H residual dipolar coupling restraints, 48 hydrogen bond restraints and 109 dihedral angle restraints (see Table 1 ) have been deposited in the Protein Data Bank (nxxx) and the restraints in the BMRB (BMRB). The rmsd for these structures is 0.74 Å for backbone atoms and 1.14 Å for all atoms ( experiments was not collectable due to an apparently longer correlation time than would be expected for a protein of this size. This indicates that the myoferlin and dysferlin DysF domains are folded. They would be expected to be similar in structure as there is 57% sequence identity 72% sequence similarity between the inner DysF domains of dysferlin and myoferlin.
Neither Secondary Structure Matching (SSM) 21 nor DALI 
Sequence conservation in DysF domains
The most highly conserved residues in the DysFN region (conserved in 65% of DysF sequences -SMART database) are a YENQ sequence and a number of tryptophans, which in myoferlin inner domain are 935YQNE and W946, W973, W975 and W980.
In the DysFC region the conserved residues are GWxY (992GWEY in myoferlin inner domain) at the N-terminal end and RRRxWxR at the C-terminal end (1019 RRRRLVR in myoferlin inner domain) (see Fig. 3, 4a ). Many of these conserved tryptophans and arginines form arginine/aromatic (R/W) stacking interactions, which is a well-known structural motif 25 . In the DysF domain, the best-defined stack consists of W946 and W993 which sandwich R1019. R1021 extends this stack. A search was performed to look for other examples of R/W stacking using JESS 26 . Using the four residues W946, R1019, W993 and R1021 as a search motif, matches were found in 17 structures in the PDB all of which were growth hormone/interleukin receptors. These receptors have 6 extracellular domains, the second and third of which are required for ligand binding. The third domain contains a WSXWS motif, which is common to a broad range of growth factor receptors. In some of the receptors, such as gp130 27 , the residues in this motif form part of a stack of three tryptophans and three arginines that is involved in the structural integrity of the domain rather than ligand binding 28 There is also a mutation in the W/R stacking of the outer domain W930C equivalent to W999C in the inner domain 20 . The polymorphism in the inner DysF region can be rationalised. R1022Q (not involved in R/W stacking) is a surface exposed side chain, which will tolerate hydrophilic substitution; it is H1003 in the myoferlin inner domain. Clearly disrupting the tight packing of the DysF domain by disrupting the W/R stacking causes dysferlinopathy almost certainly due to degradation of unfolded protein.
Discussion
The significant number of disease-causing mutations in the dysferlin gene that map to the inner DysF domain demonstrates that this domain must be correctly folded for dysferlin to be functional. However the similarities of the stacked R/W motifs between DysF and the growth hormone receptors and thrombospondin domains probably represent convergent evolution to a substructure that stabilises small sheets rather than indicating a functional similarity.
How the internal duplication has been tolerated is clear. The insertion occurs in a loop, where extending the loop to include another domain is tolerated. There are mutations reported in the linker region in the Leiden database R1060T and a duplication of residues A1064 and E1065, although the latter is reported to be a polymorphism in the Italian population but not in East Asian controls 31 . This raises the possibility of the relative orientations of the two DysF domains being important as the linker is sensitive to mutation. Domain insertion is not a rare event, especially with domains of this length -over 60% of inserted domains are less than 130 residues, and nearly 80% are less than 175 residues 32 . It is however rare for this event to occur in non-enzymatic proteins and for the parent and insert domains to be the same. One example is the PH domain complex of myosin-X, which has a PH domain inserted into another PH domain 33 .
A number of binding partners of dysferlin have been reported (for a recent review see 34 ). These include annexin A1 15 , which has been shown to be required for Ca2+-dependent membrane sealing 35 , caveolin 3 36 , which is mutated in limb girdle muscular dystrophy type 1C, AHNAK 37 and beta-parvin 38 . Interaction of dysferlin with calpain 3m which is mutated in Limb Girdle Muscular Dystrophy Type 2A, has been implied from co-association studies 39 . The C-terminus of AHNAK binds to the C2A domain of dysferlin and myoferlin 37 . The first CH domain of beta-parvin binds to the intracellular juxtamembrane section of dysferlin, in fact the pathological mutation in the inner DysF domain of dysferlin W999C did not prevent binding to beta parvin ruling out disruption of the interaction with beta parvin as a source of the pathology 38 .
The major candidate for DysF domain binding is caveolin-3, as the scaffold domain of caveolin-3 has been shown by phage display enrichment to bind W rich peptides with a motif WXWXXXXW 40 . There are conserved versions of this motif in the inner DysF domains of myoferlin and dysferlin starting at W973 of myoferlin 36 . In the outer domain the spacing is shorter between the second and third W. Although W973
and W975 makes a possible binding surface the third W980 is on the opposite face of the folded DysF domain. This supports the possibility that interaction with caveolin-3 occurs when the DysF domain is in a denatured state, as an unfolded state much more resembles the peptides selected in the Couet study than the mostly buried tryptophans in the folded structure, which do not form a single binding surface. Unfolding of the DysF domain could be a mechanism for degrading dysferlin and myoferlin at the end of the repair cycle. Some metals (nickel and zinc) precipitate the domain and this could be via aggregation of an unfolded state.
Our structural studies of the inner DysF domain of myoferlin have allowed us to rationalise the molecular basis of a significant number of the missense mutations in dysferlin. The structure resolves some of the issues of annotation of domains in the ferlins and provides a framework for fully understanding the role of this domain in Limb Girdle Muscular Dystrophy.
Materials and Methods
Sample preparation
The DysF domain cDNA, encoding residues 923-1040 of Human Myoferlin, was 
NMR Spectroscopy
Samples for NMR spectroscopy were prepared by exchanging 15 
